Castellanos Elaine
VP, Chief Accounting Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $9.5M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Jun 9, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCVP, Chief Accounting Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedOct 25 2019
Sold 2,000 shares at $190.00 ($380k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 11.7% of holdings ($3.3M position)15,146 shares left0.8x usual sizeFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedOct 28 +3 days
Sold 4,000 shares at $200.00 ($800k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 20.9% of holdings ($3.8M position)15,146 shares left2x usual sizeFiling
- 3 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedDec 2 +35 days
Sold 2,000 shares at $194.24 ($388k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 11.7% of holdings ($3.3M position)15,146 shares left0.8x usual sizeFiling
- 4 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedMar 2 +91 days
Sold 2,000 shares at $194.32 ($389k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 11.7% of holdings ($3.3M position)15,146 shares left1x usual sizeFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedJun 1 +91 days
Sold 2,000 shares at $143.97 ($288k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 11.7% of holdings ($2.5M position)15,146 shares left1x usual sizeFiling
- 6 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedNov 12 +164 days
Sold 3,500 shares at $176.02 ($616k)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 18.8% of holdings ($3.3M position)15,146 shares left1.8x usual sizeFiling
- 7 Form 4 sale REATA PHARMACEUTICALS INCUnusualMay 26 +195 days
Sold 10,000 shares at $124.55 ($1.2M)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 40.7% of holdings ($3.1M position)14,546 shares left5x usual sizeFiling
- 8 Form 4 sale REATA PHARMACEUTICALS INCUnusualJun 9 +14 days
Sold 10,000 shares at $142.65 ($1.4M)
Castellanos Elaine, VP, Chief Accounting Officer
Sold 40.7% of holdings ($3.5M position)14,546 shares left5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2021 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 10,000 | $1.4M | 40.7% | Unusual | SEC |
| May 26, 2021 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 10,000 | $1.2M | 40.7% | Unusual | SEC |
| Nov 12, 2020 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 3,500 | $616k | 18.8% | Plan not stated | SEC |
| Jun 1, 2020 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 2,000 | $288k | 11.7% | Plan not stated | SEC |
| Mar 2, 2020 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 2,000 | $389k | 11.7% | Plan not stated | SEC |
| Dec 2, 2019 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 2,000 | $388k | 11.7% | Plan not stated | SEC |
| Oct 28, 2019 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 4,000 | $800k | 20.9% | Plan not stated | SEC |
| Oct 25, 2019 | REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Form 4 sale | 2,000 | $380k | 11.7% | Plan not stated | SEC |
| Oct 18, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 2,000 | $340k | 14.4% | Plan not stated | SEC |
| Oct 15, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 14,000 | $2.1M | 54.0% | Unusual | SEC |
| Oct 14, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 3,000 | $315k | 20.1% | Plan not stated | SEC |
| Sep 6, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 2,000 | $170k | 48.3% | Unusual | SEC |
| Jun 3, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 2,000 | $170k | 48.3% | Unusual | SEC |
| Apr 8, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 2,000 | $180k | 48.3% | Unusual | SEC |
| Mar 5, 2019 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 3,588 | $366k | 62.7% | Unusual | SEC |
| Jul 23, 2018 | REATA PHARMACEUTICALS INC | Principal Accounting Officer | Form 4 sale | 7,336 | $373k | 100.0% | Unusual | SEC |